Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: Department of Health (Therapeutic Goods Administration)
cefaclor monohydrate
Sun Pharma ANZ Pty Ltd
Registered
APO-CEFACLOR CD TABLETS _Cefaclor monohydrate_ CONSUMER MEDICINE INFORMATION _FOR A COPY OF A LARGE PRINT LEAFLET, PH: 1800 195 055_ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about cefaclor. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may want to read it again. WHAT THIS MEDICINE IS USED FOR Cefaclor is used to treat infections caused by bacteria in different parts of the body, including: • chest and lungs (lower respiratory tract) • nose, throat, sinuses and tonsils (upper respiratory tract) • bladder (lower urinary tract) • skin Cefaclor belongs to a group of medicines called cephalosporin antibiotics. These are closely related to penicillin antibiotics. It works by killing the bacteria causing your infection or by stopping its growth. It will not work against infections caused by viruses such as colds or the flu. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed this medicine for another reason. This medicine is available only with a doctor's prescription. This medicine is not addictive. There is not enough information to recommend the use of this medicine in children under 12 years of age. BEFORE YOU TAKE THIS MEDICINE _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE THIS MEDICINE IF YOU HAVE AN ALLERGY TO: • cefaclor • other cephalosporins • any of the ingredients listed at the end of this leaflet. DO NOT TAKE CEFACLOR IF YOU HAVE HAD A SERIOUS ALLERGIC REACTION TO PENICILLIN. SOME OF THE SYMPTOMS OF AN ALLERGIC REACTION MAY INCLUDE: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue, throat or other pa Διαβάστε το πλήρες έγγραφο
1 AUSTRALIAN PRODUCT INFORMATION APO-CEFACLOR CD (CEFACLOR MONOHYDRATE) 375 MG TABLETS 1 NAME OF THE MEDICINE Cefaclor monohydrate. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each modified release tablet contains cefaclor monohydrate equivalent to 375 mg cefaclor. EXCIPIENT WITH KNOWN EFFECT Lactose monohydrate. For the full list of excipients see section 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM 375 MG MODIFIED RELEASE TABLET Biconvex, capsule shape and coloured blue. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of the following infections caused by susceptible organisms, in adults and children 12 years and older: • Community acquired pneumonia of mild to moderate severity (excluding atypical pneumonia). • Acute bronchitis and acute exacerbations of chronic bronchitis. • Upper respiratory infections, including pharyngitis, tonsillitis and acute bacterial sinusitis. • Symptomatic lower urinary tract infections, including cystitis. • Skin and skin structure infections. Note. 1. Penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cefaclor CD is generally effective in the eradication of Streptococci from the oropharynx; however, substantial data establishing the efficacy of Cefaclor CD in the subsequent prevention of rheumatic fever are not available. 2. Bacteriological studies to determine the causative organism and its susceptibility to cefaclor should be performed. Therapy may be started while awaiting the results of these studies. Once these results become available, antimicrobial therapy should be adjusted accordingly 2 4.2 DOSE AND METHOD OF ADMINISTRATION APO-Cefaclor CD modified release tablets are intended for oral administration. Cefaclor CD can be taken with or without food; however absorption is enhanced when Cefaclor CD is administered with food (see section 5.2 – PHARMACOKINETIC PROPERTIES). The tablets should not be cut, crushed or chewed. ADULTS The usual adult dosage Διαβάστε το πλήρες έγγραφο